Showing results (3471-3480 of 3,513) with videos related to

Sort By:
Pageof 352
Eclinicalmedicine|August 15, 2026
International approval of Chinese pharmaceuticals: a USA-anchored analysis with comparative insights from Europe and other marketsZhihao Xu, Kristina Jenei, Richard Sullivan
Eclinicalmedicine|August 26, 2026
Intergenerational contact and depressive symptoms in midlife and older adults: an analysis of six cohort studies across 33 countriesRuijie Gong, Xinyi Liu, Yalu Zhang, et al.
Eclinicalmedicine|August 26, 2026
Sex inequality in disease burden attributable to smoking, secondhand smoke and chewing tobacco: A systematic analysis for the Global Burden of Disease Study 2023Sheng Li, Zhe Xu, Brooks Morgan, et al.
Eclinicalmedicine|August 19, 2026
Intensive versus standard blood pressure control and overall brain small vessel disease burden: a post-hoc analysis of the SPRINT randomized clinical trialSokratis Charisis, Nicholas M Pajewski, Larry R Price, et al.
Eclinicalmedicine|August 20, 2026
Building a genomics-capable cancer workforce: a competency-based framework for education and training in precision oncologyAmanda Drury, Yosr Hamdi, Nicola Mulder, et al.
Eclinicalmedicine|August 23, 2026
Diagnosis, management, and prevention of Crimean-Congo haemorrhagic fever: a Delphi-based consensus study in TürkiyeÖnder Ergönül, Deniz Güllü, Defne Yigci, et al.
Eclinicalmedicine|August 23, 2026
Obesity at antiretroviral therapy initiation and long-term risk of cardiovascular disease, cancer, or death in people with HIV in Italy: a prospective cohort studyCristina Mussini, Andrea Giacomelli, Giuseppe Lapadula, et al.
Eclinicalmedicine|August 29, 2026
Long-term results of the HD0607 trial on interim PET-adapted treatment of advanced-stage Hodgkin lymphoma beyond 10 years of follow-upAndrea Visentin, Alessandro Cellini, Andrea Rossi, et al.
Eclinicalmedicine|August 30, 2026
The global cardiovascular-kidney-liver-metabolic burden from 1990 to 2023Jayanth Jayabaskaran, Haryo Raden Himan, Srinithy Nagarajan, et al.
Eclinicalmedicine|August 30, 2026
Reduced-frequency bictegravir, emtricitabine, and tenofovir alafenamide in virologically suppressed adults with HIV: a single-centre randomised phase 2 pilot trial in SpainIván Chivite, Elisa Moraga, Abiu Sempere, et al.
Pageof 352